DK0568651T3 - Bionedbrydelige polymerblandinger til afgivelse af lægemidler - Google Patents

Bionedbrydelige polymerblandinger til afgivelse af lægemidler

Info

Publication number
DK0568651T3
DK0568651T3 DK92908387T DK92908387T DK0568651T3 DK 0568651 T3 DK0568651 T3 DK 0568651T3 DK 92908387 T DK92908387 T DK 92908387T DK 92908387 T DK92908387 T DK 92908387T DK 0568651 T3 DK0568651 T3 DK 0568651T3
Authority
DK
Denmark
Prior art keywords
blends
polyesters
polyanhydrides
polymers
drug delivery
Prior art date
Application number
DK92908387T
Other languages
Danish (da)
English (en)
Inventor
Abraham J Domb
Manoj Maniar
Andrew T S Haffer
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of DK0568651T3 publication Critical patent/DK0568651T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/02—Polyesters derived from dicarboxylic acids and dihydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L73/00—Compositions of macromolecular compounds obtained by reactions forming a linkage containing oxygen or oxygen and carbon in the main chain, not provided for in groups C08L59/00 - C08L71/00; Compositions of derivatives of such polymers
    • C08L73/02—Polyanhydrides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK92908387T 1991-02-01 1992-01-31 Bionedbrydelige polymerblandinger til afgivelse af lægemidler DK0568651T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64892791A 1991-02-01 1991-02-01
PCT/US1992/000877 WO1992013567A1 (en) 1991-02-01 1992-01-31 Biodegradable polymer blends for drug delivery

Publications (1)

Publication Number Publication Date
DK0568651T3 true DK0568651T3 (da) 2002-08-05

Family

ID=24602790

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92908387T DK0568651T3 (da) 1991-02-01 1992-01-31 Bionedbrydelige polymerblandinger til afgivelse af lægemidler

Country Status (10)

Country Link
US (1) US5919835A (ja)
EP (1) EP0568651B1 (ja)
JP (1) JP3137337B2 (ja)
AT (1) ATE216262T1 (ja)
AU (1) AU669479B2 (ja)
CA (1) CA2101742C (ja)
DE (1) DE69232555T2 (ja)
DK (1) DK0568651T3 (ja)
ES (1) ES2176189T3 (ja)
WO (1) WO1992013567A1 (ja)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9301821A (es) * 1992-03-30 1994-03-31 Alza Corp Sistema de matriz polimerica biodegradable regulador de degradacion y metodo de tratamiento del mismo.
US5321113A (en) * 1993-05-14 1994-06-14 Ethicon, Inc. Copolymers of an aromatic anhydride and aliphatic ester
DE69511418T2 (de) 1995-10-28 2000-03-30 Braun Melsungen Ag Lokalanästhetika und/oder Zentralanalgetika enthaltende pharmazeutische Zusammensetzungen
US20030077317A1 (en) * 1996-06-25 2003-04-24 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
US20040171980A1 (en) 1998-12-18 2004-09-02 Sontra Medical, Inc. Method and apparatus for enhancement of transdermal transport
EP1171006B1 (en) * 1999-04-16 2006-03-29 Wm. MARSH RICE UNIVERSITY Functionalized poly(propylene fumarate) and poly(propylene fumarate-co-ethylene glycol)
US6113678A (en) * 1999-09-23 2000-09-05 Xerox Corporation Hot melt inks containing polyanhydrides
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
NZ533436A (en) * 2001-11-14 2007-10-26 Alza Corp Catheter injectable depot compositons and uses thereof
EP1446100B1 (en) * 2001-11-14 2011-05-04 Durect Corporation Injectable depot compositions and uses thereof
US20040001889A1 (en) * 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US7160551B2 (en) * 2002-07-09 2007-01-09 The Board Of Trustees Of The University Of Illinois Injectable system for controlled drug delivery
KR20050038008A (ko) * 2002-07-31 2005-04-25 알자 코포레이션 주사용 저장형 조성물 및 이의 용도
DK1539101T3 (da) * 2002-07-31 2009-04-27 Alza Corp Injicerbare, multi-modale polymere depotsammens tninger og anvendelser deraf
CA2495172A1 (en) * 2002-08-13 2004-02-19 Medtronic, Inc. Active agent delivery systems, medical devices, and methods
AU2003265446A1 (en) * 2002-08-13 2004-02-25 Medtronic, Inc. Active agent delivery system including a hydrophilic polymer, medical device, and method
US20040047911A1 (en) * 2002-08-13 2004-03-11 Medtronic, Inc. Active agent delivery system including a poly(ethylene-co-(meth)Acrylate), medical device, and method
DE60316579T2 (de) * 2002-08-13 2008-07-03 Medtronic, Inc., Minneapolis System zur abgabe von wirkstoffen mit einem hydrophoben cellulose-derivat
JP2006500088A (ja) * 2002-08-13 2006-01-05 メドトロニック・インコーポレーテッド ポリマーの被覆及び支持体間の改良された付着を示す医用デバイス
US6911400B2 (en) 2002-11-05 2005-06-28 International Business Machines Corporation Nonlithographic method to produce self-aligned mask, articles produced by same and compositions for same
US20050064038A1 (en) * 2003-08-13 2005-03-24 Dinh Thomas Q. Active agent delivery systems including a single layer of a miscible polymer blend, medical devices, and methods
EP1684820A2 (en) * 2003-08-13 2006-08-02 Medtronic, Inc. Active agent delivery systems including a miscible polymer blend, medical devices, and methods
FR2859909B1 (fr) * 2003-09-22 2007-09-07 Biomerieux Sa Procede de preparation de microparticules bioresorbables, microparticules obtenues et utilisation
US20080038317A1 (en) * 2004-09-10 2008-02-14 Chin-Ming Chang Therapeutic Lacrimal Canalicular Inserts And Related Methods
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
US20070200268A1 (en) * 2006-02-24 2007-08-30 Vipul Dave Implantable device prepared from solution processing
US20070200271A1 (en) * 2006-02-24 2007-08-30 Vipul Dave Implantable device prepared from melt processing
RU2444980C2 (ru) 2007-03-07 2012-03-20 Эко Терапьютикс, Инк. Трансдермальная система мониторинга аналита и способы детекции аналита
EP2152358B1 (en) * 2007-04-27 2011-03-02 Echo Therapeutics, Inc. Skin permeation device for analyte sensing or transdermal drug delivery
JP5139003B2 (ja) * 2007-08-17 2013-02-06 国立大学法人京都工芸繊維大学 組成物およびフィルム
US20090286907A1 (en) * 2008-01-23 2009-11-19 Beltz Mark W Fumaric Acid/Diol Polyesters and Their Manufacture and Use
TWI501781B (zh) * 2010-12-10 2015-10-01 Ind Tech Res Inst 可控制釋放的組合物及其製造方法
US20160303242A1 (en) 2013-12-09 2016-10-20 Durect Corporation Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
CN109021215B (zh) * 2018-07-11 2021-03-02 中山大学 一种pH敏感型聚扁桃酸纳米药物载体及其制备方法和应用
SG11202101047RA (en) * 2018-08-10 2021-02-25 Ephemeral Solutions Inc Particles containing coloring agents and methods of using the same
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522804A (en) * 1983-01-03 1985-06-11 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of propranolol
US4757128A (en) * 1986-08-01 1988-07-12 Massachusetts Institute Of Technology High molecular weight polyanhydride and preparation thereof
US4888176A (en) * 1984-05-21 1989-12-19 Massachusetts Institute Of Technology Controlled drug delivery high molecular weight polyanhydrides
US4886870A (en) * 1984-05-21 1989-12-12 Massachusetts Institute Of Technology Bioerodible articles useful as implants and prostheses having predictable degradation rates
US4891225A (en) * 1984-05-21 1990-01-02 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
US4764364A (en) * 1986-02-25 1988-08-16 S R I International Method of preparing bioerodible polymers having pH sensitivity in the acid range and resulting product
US4841968A (en) * 1986-09-26 1989-06-27 Southern Research Institute Antithrombotic/thrombolytic suture and methods of making and using the same
US4789724A (en) * 1986-10-17 1988-12-06 Massachusetts Institute Of Technology Preparation of anhydride copolymers
US4863457A (en) * 1986-11-24 1989-09-05 Lee David A Drug delivery device
FR2612198A1 (fr) * 1987-03-27 1988-09-16 Tyndale Plains Hunter Ltd Composition de polyurethane hydrophile et article qui en est produit
US4857311A (en) * 1987-07-31 1989-08-15 Massachusetts Institute Of Technology Polyanhydrides with improved hydrolytic degradation properties
WO1990009783A1 (en) * 1989-02-22 1990-09-07 Massachusetts Institute Of Technology Delivery system for controlled release of bioactive factors
US5356630A (en) * 1989-02-22 1994-10-18 Massachusetts Institute Of Technology Delivery system for controlled release of bioactive factors
CA2056384C (en) * 1989-06-05 1998-06-23 Tobin N. Gerhart Bioerodible polymers for drug delivery in bone
US4997904A (en) * 1989-08-25 1991-03-05 Nova Pharmaceutical Corporation Aromatic polyanhydride compositions
EP0423484B1 (de) * 1989-10-16 1993-11-03 PCD-Polymere Gesellschaft m.b.H. Pressling mit retardierter Wirkstofffreisetzung

Also Published As

Publication number Publication date
EP0568651A1 (en) 1993-11-10
ATE216262T1 (de) 2002-05-15
DE69232555T2 (de) 2002-10-31
US5919835A (en) 1999-07-06
WO1992013567A1 (en) 1992-08-20
AU669479B2 (en) 1996-06-13
DE69232555D1 (de) 2002-05-23
EP0568651B1 (en) 2002-04-17
CA2101742A1 (en) 1992-08-02
JP3137337B2 (ja) 2001-02-19
CA2101742C (en) 2005-04-12
JPH06508863A (ja) 1994-10-06
EP0568651A4 (en) 1996-11-27
ES2176189T3 (es) 2002-12-01
AU1643292A (en) 1992-09-07

Similar Documents

Publication Publication Date Title
DK0568651T3 (da) Bionedbrydelige polymerblandinger til afgivelse af lægemidler
DK0729353T4 (da) Fremstilling af bionedbrydelige mikropartikler som indeholder et biologisk aktivt middel
DE69914787D1 (de) Flüssige zusammensetzungen mit kontrollierter freigabe mit niedrigem initialfreisetzungsstoss des wirkstoffs
DK0386967T3 (da) Coatingmateriale til styring af lægemiddelafgivelse i langtidsvirkende formuleringer
KR930016091A (ko) 거의 수불용성인 약제의 고체 분산액을 제조하는 방법
FI935732A (fi) Faramceutiska formulationer av osteogeniska proteiner
KR910007516A (ko) 서방성 활성 화합물을 함유한 압착물
ME00867B (me) Tečne polimerne smeše za kontrolisano oslobađanje bioaktivnih supstanci
GEP20053474B (en) Glucocorticoid Receptor Modulators
DE69523044T2 (de) Block- und pfropfcopolymere und dazu gehöriges verfahren
NO20000913L (no) Sfæriske mikropartikler inneholdende lineære polysakkarider
ATE228528T1 (de) Modifiziere glykoside, modifizierte glyckoside enthaltende zusammensetzungen und verfahren zu ihrer herstellung
ES2129444T3 (es) Composiciones farmaceuticas.
TR199900548A2 (xx) D���k kesme kuvvetli taneleme kullan�larak dozaj birimlerinin yap�m�.
DE69906982D1 (de) Ibuprofen und domperidone enthaltende pharmazeutische zusammensetzungen
TW430559B (en) Particulate carriers and pharmaceutical compositions containing the same
KR910016314A (ko) 항생활성 성분의 치과용 국소지속성 투여조성물
JPS55129220A (en) Composition for solid preparation containing hardly soluble medicinal component having rapid action and high bioavailability
ATE175870T1 (de) Pharmazeutische zubereitung zur rektalen verabreichung von pharmakologisch wirksamen verbindungen
TH25006B (th) ยาเม็ดที่ปล่อยยาอย่างมีการควบคุม
NZ335409A (en) Use of a burst free controlled release poly(lactide/glycolide) microcapsule pharmaceutical formulation
CO4970729A1 (es) Procedimiento para formar composiciones farmaceuticas en pildoras o granulos sustancialmente esfericos de accion controlada y sostenida, que contienen como agente activo 7-bromo-1.3-dihidro-5-(2-piridinil)-2h-1,4-benzodiacepin-2 (1h)-ona; y composici
TH13630EX (th) สารผสมสำหรับการปล่อยสารตัวยาที่ทำให้นานขึ้นและได้รับการควบคุมไว้ และกรรมวิธิสำหรับการเตรียมสารผสมนี้